Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.16.3.1 (
ceruloplasmin
)
5,074
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Several features of the catalytic oxidation of cysteine by
ceruloplasmin
and nonenzymic Cu(II) at pH 7 have been compared. The oxidation of cysteine by
ceruloplasmin
has several properties in common with the Cu(II) catalyzed oxidation of cysteine: pH maxima, thiol specificity, lack of inhibition by anions, and high sensitivity to inhibition by copper complexing reagents. These two catalysts differed in their molecular activity, in their ability to oxidize penicillamine and
thioglycolate
, and in that H2O2 was produced as a primary product only during Cu(II) oxidation. The oxidation of cysteine by
ceruloplasmin
was compared also with the
ceruloplasmin
catalyzed oxidation of o-dianisidine, a classical pH 5.5 substrate. The mechanism of the oxidation of cysteine by
ceruloplasmin
at pH 7 differed from that of o-dianisidine oxidation because the latter substrate was inhibited by anions but not by copper complexing agents. Spectral and other data suggest that during the
ceruloplasmin
reaction with cysteine there is a one electron transfer from cysteine to
ceruloplasmin
resulting in the specific reduction of type 1b Cu(II).
...
PMID:Comparison of the catalytic oxidation of cysteine and o-dianisidine by cupric ion and ceruloplasmin. 711 74